Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma

MLA

Weimin Ruan, et al. “Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma.” Advanced Science, vol. 11, no. 33, Sept. 2024. EBSCOhost, https://doi.org/10.1002/advs.202402178.

APA

Weimin Ruan, Sen Xu, Yang An, Yingxue Cui, Yang Liu, Yibin Wang, Muhammad Ismail, Yong Liu, & Meng Zheng. (2024). Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma. Advanced Science, 11(33). https://doi.org/10.1002/advs.202402178

Chicago

Weimin Ruan, Sen Xu, Yang An, Yingxue Cui, Yang Liu, Yibin Wang, Muhammad Ismail, Yong Liu, and Meng Zheng. 2024. “Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma.” Advanced Science 11 (33). doi:10.1002/advs.202402178.